疏风解毒胶囊治疗急性咽炎风热证的临床观察

Clinical observation of Shufeng Jiedu Capsule for treating acute pharyngitis

目的观察疏风解毒胶囊治疗急性咽炎风热证的临床疗效及安全性。方法将120例急性咽炎风热证患者随机分为治疗组及对照组,各60例。治疗组口服疏风解毒胶囊4粒/次、3次/d,对照组服用清开灵软胶囊2粒/次、3次/d,疗程均为5 d。观察治疗前后咽痛、咽部黏膜充血程度及咽干、灼热等主次症的改善程度及积分变化。结果治疗组痊愈35例,总有效率96.67%;对照组痊愈29例,总有效率86.67%,两组疗效比较差异有统计学意义(P<0.05)。咽痛主症VAS评分,治疗组减(5.56±1.82)分,对照组减(3.00±2.27)分,两组相比差异有统计学意义(P<0.05)。不良反应发生率,治疗组为1.67%,对照组为3.33%。结论疏风解毒胶囊对治疗急性咽炎风热证疗效确切,且不良反应少,可供临床推广应用。

Objective To explore the clinical effect and safety of Shufeng Jiedu Capsule on the acute pharyngitis. Methods Patients with acute pharyngitis （120 cases） were randomly divided into two groups with treatment duration of 5 d （60 cases by Shufeng Jiedu Capsule 4#/d tid, and 60 cases by Qingkailing Soft Capsule 2#/d rid ）. The improvement and integral change of sore throat, tunica mucosa pharyngis congestion and dry throat, burning and other primary and secondary disease were observed before and after the treatment. Results The total effective rates of treatment and control groups were 96.67% and 86.66%, respectively, with significant difference between the two groups （P 〈 0.05）. The improvement of sore throat in treatment and control groups were 5.56 ± 1.82 and 3.00± 2.27, with significant difference between the two groups （P 〈 0.05）. The adverse reaction rates in treatment and control groups were 1.67% and 3.34%, respectively. Conclusion Shufeng Jiedu Capsule has a better efficacy for treating acute pharyngitis, and shows less side effect.